Atreca – Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement Post author:GHIAA Admin Post published:June 26, 2025 Post category: Continue ReadingAtreca – Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement
MedinCell – MPP, Malaria Vector Control (mdc-STM/ivermectin formulation) License Agreement Post author:GHIAA Admin Post published:June 18, 2025 Post category: Continue ReadingMedinCell – MPP, Malaria Vector Control (mdc-STM/ivermectin formulation) License Agreement
Visterra – Serum Institute of India, Dengue Fever Therapeutic, License and Collaboration Agreement Post author:GHIAA Admin Post published:May 27, 2025 Post category: Continue ReadingVisterra – Serum Institute of India, Dengue Fever Therapeutic, License and Collaboration Agreement
ViiV – MPP, HIV Prevention Medicine (Cabotegravir LA for PrEP), License Agreement Post author:GHIAA Admin Post published:May 22, 2025 Post category: Continue ReadingViiV – MPP, HIV Prevention Medicine (Cabotegravir LA for PrEP), License Agreement
UCLA – Radiopharm Theranostics, Cancer Therapeutic & Diagnostic (DUNP19 antibody) License Agreement Post author:GHIAA Admin Post published:April 28, 2025 Post category: Continue ReadingUCLA – Radiopharm Theranostics, Cancer Therapeutic & Diagnostic (DUNP19 antibody) License Agreement
UK Lambert Toolkit, Model Consortium Agreement C Post author:GHIAA Admin Post published:March 20, 2025 Post category: Continue ReadingUK Lambert Toolkit, Model Consortium Agreement C
UK Lambert Toolkit, Model Consortium Agreement B Post author:GHIAA Admin Post published:March 17, 2025 Post category: Continue ReadingUK Lambert Toolkit, Model Consortium Agreement B
UK Lambert Toolkit, Model Consortium Agreement A Post author:GHIAA Admin Post published:March 13, 2025 Post category: Continue ReadingUK Lambert Toolkit, Model Consortium Agreement A
UK Lambert Toolkit, Model Consortium Agreement D Post author:GHIAA Admin Post published:March 6, 2025 Post category: Continue ReadingUK Lambert Toolkit, Model Consortium Agreement D